Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Martínez-Sáez, O.
1602  Ergebnisse:
Personensuche X
?
1

11P Influence of ctDNA variant allele frequency (VAF) on su..:

Fructuoso, I. Garcia ; Martínez-Sáez, O. ; Conte, B....
ESMO Open.  9 (2024)  - p. 103020 , 2024
Link: https://doi.org/10.1016/..
 
?
2

12P Updated findings from the first prospective HER2DX clin..:

Martínez-Sáez, O. ; Marin, M. ; Hernández-Illán, E....
ESMO Open.  9 (2024)  - p. 103021 , 2024
Link: https://doi.org/10.1016/..
 
?
3

49P A ctDNA tool for identifying ESR1-mutated biology in ES..:

Fructuoso, I. Garcia ; Martínez-Sáez, O. ; Pardo, F....
ESMO Open.  9 (2024)  - p. 103056 , 2024
Link: https://doi.org/10.1016/..
 
?
4

14P Assessing the predictive value of HER2DX pCR-score for ..:

Martínez-Sáez, O. ; Marin, M. ; Brunet, L. Pare...
ESMO Open.  9 (2024)  - p. 103023 , 2024
Link: https://doi.org/10.1016/..
 
?
5

16P Determinants of response to short preoperative endocrin..:

Bravo, R. Gómez ; Walbaum, B. ; Schettini, F....
ESMO Open.  9 (2024)  - p. 103024 , 2024
Link: https://doi.org/10.1016/..
 
?
6

13P HER2DX ERBB2 mRNA score in first-line metastatic HER2-p..:

Bayona, R. Sanchez ; Martínez-Sáez, O. ; Romero, D.R....
ESMO Open.  9 (2024)  - p. 103022 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Unraveling the clinicopathological and molecular changes in..:

Schettini, F. ; Nucera, S. ; Brasó-Maristany, F....
ESMO Open.  9 (2024)  7 - p. 103619 , 2024
Link: https://doi.org/10.1016/..
 
?
8

8P Evaluating HER2DX pCR-Score and MRI response in predicti..:

Pascual, T. ; Martínez-Sáez, O. ; Brunet, L. Pare...
ESMO Open.  9 (2024)  - p. 103017 , 2024
Link: https://doi.org/10.1016/..
 
?
9

22P Unveiling biological and prognostic differences among p..:

Walbaum, B. ; Chic, N. ; Bruñol, C. Crous...
ESMO Open.  9 (2024)  - p. 103030 , 2024
Link: https://doi.org/10.1016/..
 
?
10

Prognostic value of HER2DX in early-stage HER2-positive bre..:

Villacampa, G. ; Pascual, T. ; Brasó-Maristany, F....
ESMO Open.  9 (2024)  3 - p. 102388 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Analytical validation of HER2DX genomic test for early-stag..:

Marín-Aguilera, M. ; Jares, P. ; Sanfeliu, E....
ESMO Open.  9 (2024)  3 - p. 102903 , 2024
Link: https://doi.org/10.1016/..
 
?
12

Prognostic value of intrinsic subtypes in hormone-receptor-..:

Schettini, F. ; Martínez-Sáez, O. ; Falato, C....
ESMO Open.  8 (2023)  3 - p. 101214 , 2023
Link: https://doi.org/10.1016/..
 
?
13

124O Patritumab deruxtecan (HER3-DXd) in hormonal receptor-..:

Oliveira, M. ; Pascual, T. ; Ortega, P. Tolosa...
ESMO Open.  8 (2023)  1 - p. 101463 , 2023
Link: https://doi.org/10.1016/..
 
?
14

55P Clinicopathological and molecular changes induced by ne..:

Schettini, F. ; Pascual, T. ; Ghiglione, L....
ESMO Open.  8 (2023)  1 - p. 101279 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Patritumab deruxtecan in untreated hormone receptor-positiv..:

Oliveira, M. ; Falato, C. ; Cejalvo, J.M....
Annals of Oncology.  34 (2023)  8 - p. 670-680 , 2023
Link: https://doi.org/10.1016/..
 
1-15